Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies.

Vibeke NorvangGina H BrinkmannKazuki YoshidaSiri LillegravenAnna-Birgitte AgaJoseph SextonSara K TedeschiHouchen LyuEllen S NorliTill UhligTore K KvienMaria D MjaavattenDaniel H SolomonEspen A Haavardsholmnull nullnull null

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2020)

A majority of patients in both cohorts reached the study-specific treatment targets. More patients in ARCTIC than in NOR-VEAC achieved ACR/EULAR Boolean remission during follow-up, suggesting that targeting a more stringent definition of remission provide further potential for favorable outcomes of a TTT strategy.

Keyphrases

end stage renal disease
rheumatoid arthritis
ejection fraction
disease activity
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
systemic lupus erythematosus
patient reported outcomes
drug delivery
risk assessment
combination therapy